Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $45.5300 (-1.19%) ($45.5300 - $45.5300) on Wed. Jun. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.26% (three month average) | RSI | 77 | Latest Price | $45.5300(-1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 6.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(47%) IWM(41%) IWO(41%) IWC(39%) IWN(39%) | Factors Impacting HALO price | HALO will decline at least -1.13% in a week (0% probabilities). VIXM(-19%) UUP(-8%) VXX(-7%) TBT(-4%) GLD(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.13% (StdDev 2.26%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $46.57(-2.23%) | 10 Day Moving Average | $45.37(0.35%) | 20 Day Moving Average | $42.82(6.33%) | To recent high | -5.7% | To recent low | 32.9% | Market Cap | $6.223b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |